Brought to you by 
Xanodyne buys aaiPharma's pharma business
24 Aug 2012
Executive Summary
Pain management and critical care drug company aaiPharma, which has filed for Chapter 11 bankruptcy, is selling the assets of its pharmaceuticals business to Xanodyne Pharmaceuticals (specializes in women's health, urology, and pain management) for $209.25mm in cash.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Xanodyne buys aaiPharma's pharma business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice